Ceva posts licensing revenue at three-year high amid AI and connectivity demand
Aug 10, 2026, 7:04 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting
Strong licensing momentum, AI IP wins, and margin improvement reduce risk of near-term profitability concerns and could trigger multiple expansion as licensing contribution sustains.
AI summary
What happened, with direct paths to the underlying reporting
Ceva reported Q2 2026 revenue of $29.0M, up 13% year over year, with licensing and related revenues rising 21% to $18.2M—the highest in three years. Royalty revenue reached $10.8M, supported by connectivity shipments and automotive AI ramps, while non-GAAP operating income rose to $3.1M (11% margin). A NeuPro-M NPU licensing win and broader connectivity licenses underscore durable AI and edge-connectivity demand.
Total Q2 2026 revenues $29.0M, up 13% YoY.
Licensing and related revenues $18.2M, up 21%, highest in 3 years.
NeuPro-M NPU IP win expands AI licensing; 10 licensing deals total.
Royalty revenues $10.8M, up 1% YoY and 17% QoQ.
Non-GAAP op income $3.1M; non-GAAP margin 11%.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event
Ceva reported Q2 2026 revenue of $29.0 million, up 13% YoY, with licensing and related revenue rising 21% to $18.2 million, a three-year high. The quarter featured ten IP licensin…
Italy's tax police have seized €27.4 million from CEVA Logistics due to ongoing investigations into tax fraud and illegal labor practices. This development could signal significan…
CEVA is nearing completion of its Adhishthana cycle, now in Phase 18, which indicates a subdued outlook. This suggests potential weakness in CEVA's stock performance and may lead…
Ceva Animal Health raised €5.5 billion, increasing valuation to €9.2 billion. Bettencourt-Meyers family boosted their stake in Ceva, indicating strong investor confidence.